← 홈

ADC

1,068개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,068개
ADCBiologicstalePierre Fabre MedicamentPhase 2

W0101 - Cohort A1 (W0101 - Cohort A1)

Advanced or Metastatic Solid Tumors · Advanced or Metastatic Solid Tumors

#AdvancedorMetastaticSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstalePierre Fabre MedicamentPhase 2

W0101 - Cohort A2 (W0101 - Cohort A2)

Advanced or Metastatic Solid Tumors · Advanced or Metastatic Solid Tumors

#AdvancedorMetastaticSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstalePierre Fabre MedicamentPhase 2

W0101 - Expansion Phase (W0101 - Expansion Phase)

Advanced or Metastatic Solid Tumors · Advanced or Metastatic Solid Tumors

#AdvancedorMetastaticSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstaleExelixisPhase 1

XB002 (XB002)

Non Small Cell Lung Cancer; Cervical Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleMersana TherapeuticsPhase 1

XMT-1522 (XMT-1522)

Advanced Breast Cancer; Advanced Nonsmall Cell Lung Cancer · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleMediLink Therapeutics (Suzhou) …Phase 2

YL202 should be intravenously infused (YL202 should be intravenously infused)

NSCLC; Breast Cancer · NSCLC

#NSCLC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleMediLink Therapeutics (Suzhou) …Phase 2

YL242 (YL242)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleMediLink Therapeutics (Suzhou) …Phase 2

YL242; 5-FU; LV (YL242; 5-FU; LV)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleZai Lab (Shanghai) Co., Ltd.Phase 1

ZL-6201 (ZL-6201)

Solid Tumors; Sarcomas · Solid Tumors

#SolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleZymeworks BC Inc.Phase 1

ZW171 (ZW171)

Mesothelin-expressing Advanced Cancers · Mesothelin-expressing Advanced Cancers

#Mesothelin-expressingAdvancedCan#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstaleZymeworks BC Inc.Phase 1

ZW191 (ZW191)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleZymeworks BC Inc.Phase 1

ZW251 (ZW251)

Hepatocellular Carcinoma; Squamous Cell Non-Small Cell Lung Cancer · Hepatocellular Carcinoma

#HepatocellularCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

[11C]AZ1419 3391 ([11C]AZ1419 3391)

Advanced Solid Malignancies · Advanced Solid Malignancies

#AdvancedSolidMalignancies#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 1

[225Ac]-FPI-2068 ([225Ac]-FPI-2068)

Advanced Solid Tumor; Metastatic Colorectal Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleVanderbilt-Ingram Cancer CenterPhase 1

[68Ga]Ga-ABY-025 ([68Ga]Ga-ABY-025)

Locally Advanced Cancer; Metastatic Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleCSPC ZhongQi Pharmaceutical Tec…Phase 1

an antibody drug conjugate (an antibody drug conjugate)

Neoplasms · Neoplasms

#Neoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 31.2%임상시험 1상태 ACTIVE
ADCBiologicstaleMabwell (Shanghai) Bioscience C…Phase 1

bulumtatug fuvedotin (bulumtatug fuvedotin)

Triple Negative Breast Cancer · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

duloxetine (duloxetine)

Solid Tumour · Solid Tumour

#SolidTumour#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleAstellasPreclinical

pembrolizumab (Keytruda, enfortumab vedotin plus pembrolizumab in first line setting for advanced upper tract urothelial carcinoma)

Advanced Upper Tract Urothelial Carcinoma · Advanced Upper Tract Urothelial Carcinom

#AdvancedUpperTractUrothelialCarc#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleDaiichi SankyoPhase 2

T-DXd (fam-trastuzumab deruxtecan-nxki, fam-trastuzumab deruxtecan-nxki (T-DXd))

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING

53 / 54 페이지

← 이전다음 →